Charles River Laboratories International CRL
NYSE CRL
$296.78 +1.68 (+0.57%)
As of: Aug 27, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) EBT Margin Growth (1y) (2010 - 2026)

Charles River Laboratories International (CRL) EBT Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 30.00
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 617.00
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 948.00
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 665.00
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -115.00
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 163.00
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -646.00
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 288.00
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 172.00
10 Charles River Laboratories International 14.28 Bn 14.09 Bn 452.07 Mn -162.00

Historic Data

Download Data
DateValue
Jun 27, 2026 -162.00
Dec 27, 2025 -796.00
Sep 27, 2025 -36.00
Jun 28, 2025 -474.00
Mar 29, 2025 -613.00
Dec 28, 2024 -4,222.00
Sep 28, 2024 -196.00
Jun 29, 2024 -48.00
Mar 30, 2024 -294.00
Dec 30, 2023 -168.00
Sep 30, 2023 -145.00
Jul 1, 2023 -267.00
Apr 1, 2023 60.00
Dec 31, 2022 419.00
Sep 24, 2022 -131.00
Jun 25, 2022 87.00
Mar 26, 2022 409.00
Dec 25, 2021 -372.00
Sep 25, 2021 -444.00
Jun 26, 2021 164.00